Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Reduce infections of HPV types prevented by the vaccine in young adults — IID‑07

Status: Baseline only

  
Baseline only
Learn more about our data release schedule

Most Recent Data:
15.1 percent (2013-16)

Target:
8.7 percent

Desired Direction:
Decrease desired

Baseline:
15.1 percent of persons aged 20 to 34 years were positive for at least 1 HPV type prevented by the 9-valent vaccine in 2013-16

See detailed data for this objective

Reduce infections due to human papillomavirus (HPV) types prevented by the 9-valent vaccine in young adults

Target-Setting Method
Percentage point improvement

Data Source:  National Health and Nutrition Examination Survey (NHANES), CDC/NCHS

Learn more about data measurement for this objective

Summary

Every year in the United States, HPV (human papillomavirus) causes many cases of cancer that could be prevented with vaccination. Routine vaccination is recommended at age 11 to 12 years, but many people who need to get the vaccine don’t. Encouraging health care providers to recommend the vaccine is critical for reducing HPV infections.

Topics:  Infectious Disease, Adolescents , Sexually Transmitted Infections, Vaccination

Workgroup: Immunization and Infectious Diseases Workgroup

Other objectives you may be interested in

Browse all Healthy People 2030 objectives